Latest news
New Melanoma Drug Based On Herpes Virus Granted FDA Accelerated Approval - U.S. News & World ReportU.S. News & World Report · Mon, 10 Aug 2026 14:58:00 GMTThird time’s the charm for Replimune as melanoma drug earns FDA greenlight - BioSpaceBioSpace · Thu, 06 Aug 2026 22:18:12 GMTFDA Finally OKs Twice-Rejected Melanoma Drug - MedPage TodayMedPage Today · Thu, 06 Aug 2026 21:40:02 GMTFDA Approves Replimune’s Melanoma Drug on Third Attempt - WSJWSJ · Thu, 06 Aug 2026 20:46:00 GMTFDA approves Replimune melanoma drug previously rejected twice - STATSTAT · Thu, 06 Aug 2026 20:04:45 GMTFDA Advisory Panel Backs Replimune's Melanoma Drug - MedscapeMedscape · Fri, 31 Jul 2026 15:17:18 GMTAdcomm backs Replimune melanoma drug, despite data concern - pharmaphorumpharmaphorum · Fri, 31 Jul 2026 07:00:00 GMTReplimune melanoma drug wins support of FDA panel - BioPharma DiveBioPharma Dive · Thu, 30 Jul 2026 07:00:00 GMT